Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies

NCT01745913 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Acute Myelogenous Leukemia
Myelodysplastic Syndrome
Acute Lymphocytic Leukemia
Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma

Interventions

DEVICE: CliniMACS® CD34 Reagent System
DRUG: Fludarabine
DRUG: Melphalan
DRUG: Rabbit ATG
PROCEDURE: Double Umbilical Cord Blood Transplantation
PROCEDURE: Haplo-Identical Cord Transplantation

Sponsor

Weill Medical College of Cornell University